Ameritas Investment Partners, Inc.

Position in CTMX — CytomX Therapeutics, Inc.

CIK 1055980 LINCOLN, NE

Position in CTMX

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$60,577

+$47,201 QoQ

Shares Held

16,154

+222.4% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#141

of 178 holders

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Ameritas Investment Partners, Inc. holds $62,741,652 across 267 Biotechnology names. CTMX ranks #131 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	12,422	$6,170,379
2	EXEL	Exelixis, Inc.	75,969	$4,133,473
3	HALO	Halozyme Therapeutics, Inc.	40,729	$3,187,858
4	CYTK	Cytokinetics Inc	36,992	$3,151,348
5	ROIV	Roivant Sciences Ltd.	83,064	$2,939,634
6	REGN	Regeneron Pharmaceuticals, Inc.	4,593	$2,863,919
7	JAZZ	Jazz Pharmaceuticals plc	11,547	$2,782,480
8	ARWR	Arrowhead Pharmaceuticals, Inc.	25,923	$2,112,983

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$60,577	16,154	+222.4%	Shares	Other	2026-08-13
2022-03-31	$13,376	5,010	0.0%	Shares	Other	2022-05-13
2021-12-31	$21,693	5,010	0.0%	Shares	Other	2022-02-11
2021-09-30	$25,500	5,010	0.0%	Shares	Other	2021-11-15
2021-06-30	$31,713	5,010	0.0%	Shares	Other	2021-08-06
2021-03-31	$38,727	5,010	+35.8%	Shares	Other	2021-05-14
2020-12-31	$24,162	3,689	0.0%	Shares	Other	2021-02-12
2020-09-30	$24,531	3,689	0.0%	Shares	Other	2020-11-13
2020-06-30	$30,729	3,689	0.0%	Shares	Other	2020-08-05
2020-03-31	$28,294	3,689	—	Shares	Other	2020-05-13
No filing history on record for this holder in this stock.